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miRNAParkinson's disease (PD) is a complex neurological disorder of the elderly population and majorly shows the se-
lective loss of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNpc) region of the brain.
The mechanisms leading to increased cell death of DAergic neurons are not well understood. Tumor necrosis
factor-alpha (TNF-α), a pro-inﬂammatory cytokine is elevated in blood, CSF and striatum region of the brain in
PD patients. The increased level of TNF-α and its role in pathogenesis of PD are not well understood. In the cur-
rent study, we investigated the role of TNF-α in the regulation of cell death and miRNAmediated mitochondrial
functions using, DAergic cell line, SH-SY5Y (model of dopaminergic neuron degeneration akin to PD). The cells
treated with low dose of TNF-α for prolonged period induce cell death which was rescued in the presence of
zVAD.fmk, a caspase inhibitor and N-acetyl-cysteine (NAC), an antioxidant. TNF-α alters mitochondrial
complex-I activity, decreases adenosine triphosphate (ATP) levels, increases reactive oxygen species levels and
mitochondrial turnover through autophagy. TNF-α differentially regulatesmiRNA expression involved in patho-
genesis of PD. Bioinformatics analysis revealed that the putative targets of altered miRNA included both pro/anti
apoptotic genes and subunits of mitochondrial complex. The cells treated with TNF-α showed decreased level of
nuclear encoded transcript ofmitochondrial complexes, the target ofmiRNA. To our knowledge, the evidences in
the current study demonstrated that TNF-α is a potential regulator ofmiRNAswhichmay regulatemitochondrial
functions and neuronal cell death, having important implication in pathogenesis of PD.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease (PD) is the most common neurodegenerative
disorder, affecting millions of elderly individuals worldwide [1,2]. The
increase in aging population is already showing exponential rise in PD
cases. The mechanisms leading to PD had been the focus of research
for the last several years; however, there is no effective therapy or any
potential marker for monitoring the progression of PD. Neuropatholog-
ical examination of the post-mortem brain suggests that several regions
of the brain are affected, however the loss of dopaminergic (DAergic)
neurons in the substantia nigra pars compacta (SNpc) is one of the
most prominent features of PD [3]. At the time of clinical presentation
approximately 50–70% of DAergic neurons in the nigrostriatal system
are already lost [4]. Themechanisms leading to degeneration of DAergic
neurons are still not well understood.
Inﬂammation and its association with neurodegenerative diseases
are emerging [5,6]. Several studies provide strong evidences for the as-
sociation of inﬂammation with sporadic and familial forms of the PD.
The studies of post-mortem human brain obtained from PD patientsprovided direct evidence of the association with inﬂammation with
PD. HLA-DR-positive reactive microglia were clearly observed within
the substantia nigra of PD patients [7]. The increased levels of several
pro-inﬂammatory cytokines (IL1-β, IL-2, IL-6, TNF-α and IFN-γ) were
observed in the DAergic nigrostriatal system and the regions outside
the SN in PD patients [8–13]. TNF-α is one of the important pleiotropic
cytokines and had been implicated in both neuronal survival and death.
TNF-α is known to induce ROS (reactive oxygen species) generation in
mitochondria [14]. Themitochondrial complex I and complex III are the
primary sites of ROS generation. The homeostasis of mitochondria is
maintained through selective elimination of defective mitochondria by
the process of selective autophagy called as mitophagy [15]. The role
of TNF-α in regulation of mitochondrial dysfunction, generation of
ROS and implication in mitophagy during PD conditions is not well
understood.
The optimal functioning of mitochondria requires more than 1000
proteins. Hence N1000 resident proteins and critical non-coding RNAs
(RNaseP, RNA component of MRP and 5S rRNA) are encoded from nu-
clear genome and are imported into mitochondria for their optimal
function [16]. The miRNAs, emerging class of small non-coding RNAs,
play important role in the regulation ofmRNA copy number and protein
level in the narrow physiological range [17]. Recently, our group
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with mitochondria [18]. The translation of mRNA encoding mitochon-
drial proteins occurs in close proximity to mitochondria [19]. The asso-
ciation of miRNA to mitochondria suggest its important implication in
the regulation of nuclear encoded mitochondrial transcripts. The role
of miRNA in the regulation of mitochondrial functions in the presence
of TNF-α and its implication in PD progression are not well understood.
In the current study we investigated the role of TNF-α in the regula-
tion of cell death and miRNA mediated mitochondrial functions using
DAergic neuronal cells (SH-SY5Y, model of dopaminergic neuron de-
generation similar to PD). We observed that increased levels of TNF-α
alter the miRNAs targeting nuclear encoded mitochondrial complex-I
subunits, induce mitochondrial oxidative stress by dysregulation of
complex-I activity and induce cell death.2. Materials and method
2.1. Cells and reagents
SH-SY5Y cells were grown at 37 °C, 5% CO2 in Dulbecco's Modiﬁed
Eagle's Medium: NutrientMixture F-12 (DMEM/F12, Gibco, Invitrogen)
supplemented with 15% (v/v) heat-inactivated fetal bovine serum
(Gibco, Invitrogen) and 1% penicillin, streptomycin, and neomycin
(PSN) antibiotic mixture (Gibco, Invitrogen). GFP-LC3 was provided
by Dr. T. Yoshimori (National Institute of Genetics, Shizuoka, Japan)
[20]. α-Synuclein-GFP was provided by Dr. Patrik Brundin (Neuronal
Survival Unit, Wallenberg Neuroscience Center, Sweden). The primary
antibodies used were: mouse monoclonal against caspase-9 (Cell Sig-
naling, USA), rabbit polyclonal against caspase-3 (Cell Signaling, USA),
PARP (Cell Signaling, USA), LC3 (Sigma, USA) and β-actin (Abcam,
USA). Secondary antibodies: HRP-conjugated anti-rabbit and anti-
mouse antibodies (Open Biosystems, USA) were used in the study.
Rotenone, H2O2, 6-OHDA, N-acetyl-cysteine (NAC), Antimycin A, Sodi-
um azide, Decylubiquinone, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT), Acridine orange and Propidium Iodide
(PI) were purchased from Sigma-Aldrich, USA. TNF-α was purchased
from Enzo Life Science (USA), z-VED.fmk from Invivogen (USA), SYBR
green fromTakara (Japan), ﬁrst strand cDNAkit,miRCURYmiRNA isola-
tion kit from Exiqon (Denmark), Anti-miR-155 from Ambion (USA),
Tetramethylrhodamine, methyl ester (TMRM) and ATP assay kit from
Invitrogen (USA).2.2. Cell death assay
The cell viability was analyzed by MTT assay and Acridine/
Propidium Iodide staining. SH-SY5Y cells were plated at the density of
1 × 104 cells/per well in 96 well plate. After 24 h of culture, the cells
were treated with indicated chemicals. MTT assay was performed at
speciﬁed time intervals by incubating cells with MTT (0.1 mg/ml) at
37 °C for 1–2 h. The visible blue crystals were solubilized in DMSO and
the absorbance was measured at 510 nm using microplate reader
μQuant (Biotech Instruments, USA).
For Acridine/Propidium Iodide staining, the cells were plated in
24 well plate at the density of 1.5 × 105 cells/well. The cells were cul-
tured in the presence of TNF-α (20 ng/ml) for 72 h. The Acridine
orange/Propidium iodide (0.025 μg/ml and 0.033 μMrespectively) solu-
tion was added to cells, plates were centrifuged and images were cap-
tured using GFP and RFP ﬁlter by IX81 ﬂuorescent microscope
(Olympus, Japan). Images were captured in monochrome and pseudo-
colored and analyzed for green (healthy), orange (apoptotic) and
red cells (late apoptotic or necrotic) using Image-Pro Plus (Media
Cybernetics, USA). Caspase3/7 activation assay was performed using
Caspase-Glo® 3/7 Assay kit (Promega, USA), according to the
manufacturer's protocol.2.3. Western blotting
Cells were treated with TNF-α for indicated time periods. Cells were
harvested, washed with ice cold PBS and lysed in NP40 lysis buffer
(150 mM NaCl, 50 mM Tris-Cl, 1% NP40, 1 mM PMSF). Protein concen-
tration was determined by Bradford assay and equal protein loaded
on 12% SDS-PAGE. Protein was electroblotted on PVDF membrane at
110 V for 1 h. Following the transfer, the membrane was blocked with
5% blocking buffer (5% non-fat dried milk and 0.1% Tween-20 in TBS)
for 1 h at room temperature. The membrane was incubated overnight
with speciﬁc primary antibody. After incubation the membrane was
washed three times with TBS-T (TBS containing 0.1% Tween 20) for
10 min and incubated with a secondary antibody at room temperature
for 1 h. The membrane was similarly washed three times with TBS-T
and protein bands on the membrane were then visualized by using
EZ-ECL chemiluminescence detection kit for HRP (Invitrogen, USA) by
exposing to X-ray ﬁlm.
Mitophagy was checked by western blotting of mitochondrial frac-
tion by analyzing the conjugation of LC3 to mitochondria by western
blotting using LC3 speciﬁc antibody. Mitochondrial fraction was pre-
pared using differential centrifugation method [21] and lysed in Triton
X100 lysis buffer.Western blottingwas preformed asmentioned above.
2.4. Generation of stable cell line
The stable cell line SH-SY5Y-MTRFP was generated to study the
mitophagy and mitochondrial dynamic. To generate SH-SY5Y-MTRFP
stable cell line, 1.5 × 105 cells of SH-SY5Y were plated in 24 well plate
and transfected with mitochondrial targeted red ﬂuorescent protein
vector (pHcRed1-Mito) (Clonetech, USA) using FUGENE HD Transfec-
tion Reagent (Roche, Germany) according to the manufacturer's proto-
col. Media was replaced with DMEM-F12 supplemented with G418
(500 μg/ml) after 48 h of transfection and every alternate day until
stable clones were clearly visible. The stable cells were harvested from
24 well plate and transferred to 96 well plate to obtain single clone
using serial dilution method. The single clones were transferred and
maintained in 6 well plate. After incubation for 15 days, the cells were
transferred to 25 cm2 culture ﬂask and maintained in DMEM-F12 sup-
plemented with 50 μg/ml of G418.
2.5. Analysis of mitophagy by confocal microscopy
SH-SY5Y-MTRFP cells were plated at the density of 1.5 × 105 cells
per well in 24 well plate having coverslip and transfected with GFP-
LC3 using FuGENE HD Transfection Reagent (Roche, Germany). After
24 h of transfection, the cells were treated with 20 ng/ml of TNF-α for
72 h and co-localization of GFP-LC3 with mitochondria was monitored
using Leica TCS-SP5-II confocal microscope (Germany).
2.6. Analysis of reactive oxygen species and mitochondrial membrane
potential
ROS was analyzed by microscopy and spectroﬂuorometry using
MitoSOX as mitochondria ROS indicator. SH-SY5Y cells were treated
with 20 ng/ml of TNF-α for 48 h. After incubation for indicated time,
the cells were stained with MitoSOX Red (1.0 μM) (Invitrogen, USA)
in DMEM-F12 for 10 min at 37 °C. Cells were washed three times in
fresh DMEM-F12. Images were captured using 10× objective (Olympus
IX81 microscope) having same exposure for each well.
The relative quantiﬁcation of ROS was analyzed by spectroﬂuorom-
etry. Cells were harvested after treatment as indicated. Cells were
suspended in DPBS containing MitoSOX Red (1.0 μM) (Invitrogen,
USA) for 10 min. The cells were washed with DPBS and ﬂuorescence
was analyzed by ﬂuorescence spectrophotometer (Hitachi, Japan) at
Excitation 510 and Emission 580.
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ﬂuorometry using TMRM staining. SH-SY5Y cells were loaded with
TMRM (200 nM) (Invitrogen, USA) for 15 min after treatment with in-
dicated chemicals. The cells were washed in DPBS and ﬂuorescence
was analyzed by ﬂuorescence spectrophotometer (Hitachi, Japan) at Ex-
citation 540 and Emission 570.
2.7. Analysis of complex-I activity
Complex-I activity was determined by BN-PAGE (Blue-Native Page)
and Spectro-Photometry. BN-PAGE was performed as described
previously [22,23] with minor modiﬁcations. Acrylamide (50% w/v)/
Bisacrylamide (0.5% w/v) solution was prepared such that it yielded
highly porous gels on polymerization, for the separation of higher
order protein complexes. The ﬁnal concentration of the stacking gel
was 4% and that of the resolving gel was 10%. Puriﬁed mitochondrial
fraction was mixed with sample buffer and non-gradient BN-PAGE
was performed at room temperature as described previously [22]. The
gel was stained with complex-I staining solution (50 mM potassium
phosphate buffer (pH 7.0) containing 0.2 mg/ml NBT and 0.1 mg/ml
NADH). All gel images were documented using an Epson Perfection
1670 scanner.
The activity of complex-I was determined using decylubiquinone as
the electron acceptor and NADH as donor. Brieﬂy, cells were harvested
and washed with cold DPBS. Cells were subjected to freeze-thawing
two or three times in Freeze–Thaw complete solution (0.25 M Sucrose,
20 mM Tris–HCl (pH 7.4), 40 mM KCl, 2 mM EDTA supplemented
with 1 mg/ml fatty acid free BSA, 0.01% Digitonin and 10% Percoll).
After completion of the freeze-thawing process, the cells were washed
with Freeze–Thaw solution devoid of digitonin to remove the residual
digitonin as it interferes with the complex-I enzyme assay. Cells were
suspended in complex-I assay buffer (35 mM Potassium Phosphate
(pH—7.4), 1 mM EDTA. 2.5 mMNaN3, 1 mg/ml BSA, 2 μg/ml Antimycin
A, 5 mMNADH). Complex-I activity wasmeasured for 3 min by follow-
ing the decrease in absorbance at 340 nm after the addition of 2.5 mM
acceptor decylubiquinone indicating the oxidation of NADH.
2.8. ATP luciferase assay
Total and mitochondrial ATP was performed by using ATP Biolumi-
nescence kit CLS II (Invitrogen, USA). Brieﬂy, SH-SY5Y cells were treated
with TNF-α for 72 h. Mitochondrial fraction was isolated by differential
centrifugation method [21]. Total cell and mitochondrial fractions were
lysed in 0.1% Triton X-100 andATP levels were analyzed using Lumines-
cent ATP Detection Assay Kit (Invitrogen, USA) according to the
manufacturer's instructions. ATP concentration was calculated by plot-
ting standard curve.
2.9. miRNA isolation and analysis by Quantitative Real Time-PCR
(qRT-PCR)
SH-SY5Y were plated at density of 5 × 105 cells/well in 6 well plate
and treated with 20 ng/ml of TNF-α for 72 h. miRNAs were isolated
using miRCURY miRNA isolation kit (Exiqon, Denmark) according to
the manufacturer's protocol.
The expression of miRNAswas determined by qRT-PCR. For analysis
of miRNA expression, Poly-A tailing of 100 ngmiRNA was performed at
42 °C for 1 h using PolyA polymerase (NEB, USA). The cDNAwas synthe-
sized using universal degenerate primer and Universal RT mix (Applied
Biosystems, USA). qRT-PCR was performed with SYBR Premix Ex Taq II
(Takara, Japan)with StepOnePlus™ (Applied Biosystem, USA) for 35 cy-
cles of 95 °C for 15 s and 60 °C for 60 s. 5S rRNAwas used as endogenous
control.
The targetmRNA levels were also analyzed by qRT-PCR. Brieﬂy, total
RNAwas isolated using Tri Reagent (Life technologies, USA) andwas re-
verse transcribed to synthesize cDNA using cDNA Universal RT mix(Applied Biosystems, USA) according to themanufacturer's instructions.
qRT-PCR was performed using SYBR Premix Ex TaqTM (Takara, Japan)
as per the manufacturer's instructions for 35 cycles of 95 °C for 5 s and
60 °C for 34 s. GAPDH was used as endogenous control. The relative
amount of each gene and miRNA was measured using the 2(−ΔΔCT)
method [24]. The relative association with standard error was plotted
using Graph Pad PRISM 5.0.
2.10. Target analysis
The validatedmiRNAswere categorized into upregulated and down-
regulated columns based on the qPCR results. The target pathways of se-
lectedmiRNA functionwere determined by selecting all miRNAs of each
category, combination of all 5 target prediction tools and ClipSeq with
low stringency and corrected p-value b 0.05 [25]. The GO terms and
pathways were retrieved for each category and tabulated.
2.11. Statistical analysis
Data are shown asmean±SEM for no. of observations. Comparisons
of groups were performed using ANOVA, Tukey's Multiple Comparison
test and Student's t-test for repeated measurements to determine the
levels of signiﬁcance for each group. Each experiment has been repeated
minimum two times independently and probability values of p b 0.05
were considered as statistically signiﬁcant.
3. Results
3.1. Prolonged exposure of TNF-α induces cell death in SH-SY5Y
The previously reported clinical studies had provided evidence that
TNF-α level is increased in both serum and CSF (cerebral spinal ﬂuid)
in PD patients [13,26,27]. This strongly suggests its important role in se-
lective neuronal loss however; its role in pathophysiology of PD is not
well understood. In the current study, SH-SY5Y cells (in-vitro model
of dopaminergic neuron) were treated with low concentration of TNF-
α (20 ng/ml) for different time periods. The soluble TNF-α can bind to
TNFR1 and TNFR2 [28], hence the expression pattern of both TNFR1
and TNFR2 in SH-SY5Y was analyzed in the presence/absence of TNF-
α using real time PCR. The expression of TNFR1 increased signiﬁcantly
in the presence of TNF-α whereas there was no change in TNFR2 ex-
pression (Fig. S1). The binding of TNF-α to TNF-R1 can lead to cell sur-
vival and death pathway [29] hence further studies were done to
conﬁrm the role of TNF-alpha in neuronal survival/death. SH-SY5Y
cells were treated with different doses of TNF-α for prolonged period
and cell survivalwasmonitored usingMTT assay (Fig. S2A). The cell sur-
vival signiﬁcantly decreased after 72 h of TNF-α treatment as compared
to untreated cells (Fig. 1A). The high level of cell death (N30%) was ob-
served after 96 h of TNF-α treatment (Fig. 1A).
To determine the type of cell death on prolonged exposure of
TNF-α, Acridine orange/Propidium Iodide staining was performed.
The cells stained orange (Fig. 1B) and number increased signiﬁcantly
(Fig. S2B) after 72 h of TNF-α treatment, suggesting that the cell
death is mediated by apoptosis. The induction of apoptosis was fur-
ther conﬁrmed by monitoring the PARP cleavage and caspase activa-
tion. PARP is a target of executioner caspases and is cleaved during
apoptosis [30,31]. The western blotting showed 110 kDa correspond-
ing to native form of PARP in control as well as TNF-α treated cells.
The band of 89 kDa corresponding to cleaved PARP was observed
only after 72 h of TNF-α treatment. The cleaved form of PARP was
not detected in the untreated cells (Fig. 1C). PARP cleavage strongly
suggests the role of caspases in TNF-α induced cell death. Further ex-
periments were performed to conﬁrm the activation of caspases and
their role in TNF-α induced cell death. SH-SY5Y cells treated with
TNF-α showed the band of 18 kDa corresponding to cleaved subunit
of caspase-3 after 72 h whereas it was not detected till 48 h of TNF-α
Fig. 1. TNF-α induces apoptotic cell death in SH-SY5Y cells. (A) SH-SY5Y cells were treatedwith TNF-α (20 ng/ml) for indicated time period andMTT assay was performed for the analysis
of cell survival. (B) TNF-α induces apoptosis. SH-SY5Y cells were treated with TNF-α (20 ng/ml) for 72 h. The analysis of the type of cell death was monitored by Acridine orange/
Propidium Iodide staining. (C) TNF-α activates caspase-3 and 9 in DAergic cells. SH-SY5Y cells were treated with TNF-α (20 ng/ml) for different time periods. The activation of cas-
pase-3 and 9 was monitored by western blotting using speciﬁc antibodies. Asterisk (*) indicates that p value b 0.05, for SEM.
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9 used in the study detects only 48 kDa precursor form of caspase-9.
The decreased level of 48 kDa band was observed only after 72 h of
TNF-α treatment (Fig. 1C). This strongly suggests the activation of
caspase-9 in the presence of TNF-α. These observations collectively
suggest that prolonged exposure of low doses of TNF-α to dopami-
nergic neuronal cells, SH-SY5Y induces apoptosis.3.2. TNF-α sensitizes SH-SY5Y cells to PD stress induced cell death
Neurotoxicants like Rotenone, 1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine (MPTP) or 6-hydroxydopamine (6-OHDA) induce PD
like conditions in experimental animalmodels [32] and induce degener-
ation of DAergic neurons. SH-SY5Y expresses tyrosine hydroxylase and
dopamine transporter and can preferentially uptake 6-OHDA [33]. It
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Similarly, Rotenone freely enters into the cells and induces neuronal
death by inhibiting complex-I activity [34]. We further analyzed if
TNF-α sensitizes dopaminergic neurons to cell death in PD stress condi-
tions (Rotenone and 6-OHDA). SH-SY5Y cells were co-treatedwith sub-
toxic doses of 6-OHDA and TNF-α. The cell viability was analyzed by
MTT assay. The cell viability signiﬁcantly decreased in the presence of
TNF-α and 6-OHDA as compared to 6-OHDA alone and untreated cells
(Fig. 2A). Similar experiments were performed in the presence of rote-
none. The presence of TNF-α sensitized rotenone induced cell death as
compared to untreated or treated either of them (Fig. 2B). The high
levels of α-synuclein expression are known to produce PD-like cellular
and axonal pathologies in the nigrostriatal region of both rodents' and
primates' brain [35]. Therefore the role of TNF-α was also checked in
cell death during α-synuclein mediated in PD stress condition. To con-
ﬁrm this, α-synuclein-GFP was transfected in SH-SY5Y and treated
with TNF-α for 72 h and cell death was monitored by PI Staining. The
number of PI positive/α-synuclein-GFP transfected cells signiﬁcantlyFig. 2. TNF-α sensitizes SH-SY5Y to cell death in PD stress conditions. (A) SH-SY5Y cells were co
for 24 h. Cell viability was analyzed byMTT assay. (B) SH-SY5Y cells were treatedwith Rotenon
vival assessment. (C) SH-SY5Y cells were transfected with α-synuclein-GFP and vector control
positive cell/ Transfected was assessed by PI staining. Asterisk (*) indicates that p value b 0.05increased in the presence of TNF-α (Fig. 2C). Collectively, these results
suggest that TNF-α sensitizes SH-SY5Y to cell death in the presence of
different PD stress conditions.
3.3. TNF-α induces mitochondrial oxidative stress in SH-SY5Y cells
The dysregulation of mitochondria and oxidative stress is one of the
primary features of PD stress conditions. The activation of caspase-9 and
caspase-3 cascade suggests the dysregulation of mitochondrial func-
tions in the presence of TNF-α, which may be one of the reasons for in-
creased cell death in PD stress conditions. To elucidate the role of TNF-α
in oxidative stress, the generation of ROS at mitochondria was moni-
tored by MitoSOX staining. The dye permeates live cells where it is
selectively targeted tomitochondria, oxidized by superoxide and gener-
ates red ﬂuorescence. The number of MitoSOX positive cell signiﬁcantly
increased in the presence of TNF-α as compared to untreated cells
(Fig. 3A) suggesting the induction of mitochondrial ROS. Quantiﬁcation
ofMitoSOXﬂuorescencewas performed by spectroﬂuorometrymethod-treatedwith indicated sub-toxic doses of 6-OHDA (25 μM, 40 μM) and TNF-α (20 ng/ml)
e (25 μM/ml) for 24 h in the presence of TNF-α andMTT assaywas performed for cell sur-
followed by TNF-α (20 ng/ml) treatment. After 72 h of treatment % PI (Propidium Iodide)
, for SEM.
Fig. 3. TNF-α inducesmitochondrial oxidative stress and cell death. (A) SH-SYSY cells were treatedwith TNF-α for 48 h.MitoSOX stainingwas performed tomonitor ROS production using
ﬂuorescence microscope. (B and C) SH-SY5Y cells were treated with TNF-α, NAC and z-VAD.fmk either alone or in combination. (B) After 96 h of treatment, cell survival was assessed by
MTT assay and (C) caspase 3/7 activity was measured using caspases 3/7 Luciferase assay. Asterisk (*) indicates that p value b 0.05, for SEM.
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cence intensity was observed in the presence of TNF-α (Fig. S3A) sug-
gesting the generation of mitochondrial ROS. The generation of ROS
may lead to the loss of mitochondrial membrane potential (ΔΨ),
hence TMRM staining was performed in the presence and absence of
TNF-α. The ﬂuorescence intensity signiﬁcantly decreased in the pres-
ence of TNF-α (Fig. S3B). To further conﬁrm the role of TNF-α induced
oxidative stress in induction of DAergic neuronal death, the cell survival
was monitored in the presence of antioxidant (NAC) and caspase in-
hibitor (z-VED.fmk). TNF-α induced cell death was rescued by NAC
and z-VED.fmk (Fig. 3B). The activity of caspase3/7 signiﬁcantly in-
creased in the presence of TNF-α and decreased in the presence of anti-
oxidant and caspase inhibitor (Fig. 3C). The results here demonstrated
that TNF-α induces oxidative stress and subsequently activates caspase
dependent cell death pathway in SH-SY5Y cells.
3.4. TNF-α regulates mitochondrial complex-I in dopaminergic cells
The above experiment showed increased oxidative stress in the
presence of TNF-α suggesting compromised mitochondrial functions.
The mitochondrial complex-I is the entry point of the electrons in the
electron transport chain (ETC) [36]. The dysregulation of mitochondrial
complex-I results in leakage of electrons and is one of the primary
sources of ROS [36]. However, its regulation in the presence of TNF-αand its implication in PD stress are not well understood. Hence, we
monitored the mitochondrial complex-I activity by spectrophotometric
assay and BN-PAGE. The spectrophotometric assay showed that
complex-I activity signiﬁcantly decreased in the presence of TNF-α.
The decrease in complex-I activity was observed as early as 36 hwhere-
as the caspase activation and cell deathwere evident after 72 h of TNF-α
treatment as compared to untreated cells (Fig. 4A). To further conﬁrm
this observation, BN-PAGE was performed and in-gel assay for
complex-I showed decreased activity in the presence of TNF-α treated
cells as compared to untreated cells (Fig. 4B). This suggests that dysreg-
ulation of complex-I precedes the cell death in the presence of TNF-α.
TNF-αmediated decrease in mitochondrial complex-I activity may
also affect ATP levels in the cells. The total relative cellular and mito-
chondrial ATP levels were determined in the presence/absence of TNF-
α. In TNF-α treated cells, both total cellular and mitochondrial ATP
levels signiﬁcantly decreased as compared to untreated cells (Fig. 4C
and D). These evidences strongly suggest that mitochondrial functions
may be dysregulated in the presence of TNF-α.
The mitochondrial homeostasis is required for the optimal function
of the cell [37]. The defective mitochondria are eliminated by selective
process of autophagy called asmitophagy [38,39]. However, TNF-αme-
diated regulation of mitophagy and its implication in PD disease are
not well understood. Mitophagy was monitored by co-localization of
autophagy marker (LC3 protein) with mitochondria by confocal
Fig. 4. TNF-α regulates mitochondrial complex-I activity in SH-SY5Y cells. (A) SH-SY5Y
cells were treated with TNF-α at different time periods. Complex-I activity was measured
at indicated time point of TNF-α treatment by monitoring the decrease in absorbance at
340 nm. (B) Blue Native gel electrophoresis of Triton-X 100 solubilized mitochondrial ex-
tracts fromTNF-α treated and untreated SH-SY5Y cellswas performed. The gel stripswere
stained with complex-I staining solution. (C and D) After 72 h of TNF-α treatment, ATP
levels in untreated and TNF-α treated condition were measured by ATP-dependent lucif-
erase activity. (C) ATP level in whole cell lysates. (D) ATP level in mitochondrial fraction.
Asterisk (*) indicates that p value b 0.05, for SEM.
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transfected with GFP-LC3 and co-localization was analyzed by confocal
microscopy. The co-localization of green LC3 puncta and red mitochon-
dria was clearly observed in the presence of TNF-α as compared to un-
treated cells (Fig. 5A) and signiﬁcantly increased in the presence of TNF-
α (Fig. S4D). We also hypothesized that mitochondria undergoing
mitophagy may be conjugated with LC3 hence we performed western
blotting in the presence/absence of TNF-α and rotenone (as positive
control for mitophagy inducer). The LC3-II forms, which represent the
lipidated form of LC3, increased signiﬁcantly in the mitochondrial frac-
tion in the presence of rotenone (inhibitor of complex-I, positive con-
trol). The lipidated form of LC3 increased in the presence of TNF-α as
compared to untreated cells however it was low as compared to rote-
none (Fig. 5B). The level of autophagywas also analyzed in the presence
of TNF-α bywestern blotting of LC3. The levels of lipidated form of LC3-
II increased in the presence of TNF-α. The turnover increased till 36 h as
the levels of LC3-II form increased in the presence of baﬁlomycin.Interestingly, the level of LC3-II did not change in the presence of
baﬁlomycin (inhibitor of vacuolar H + ATPase (V-ATPase)) after
prolonged incubation of 48 and 72 h [40], suggesting the decreased
turnover of autophagosome to the lysosome (Fig. S4A). Taken together,
all these suggest that the increased levels of TNF-α alter the mitochon-
drial complex-I activity, induce oxidative stress, and altermitochondrial
turnover through mitophagy which may have important implication in
PD conditions.
3.5. TNF-α regulates miRNA expression targeting mitochondrial functions
The evidences in the current study strongly suggest that mitochon-
drial function is compromised in the presence of TNF-α and leads to
cell death. The optimal functioning of mitochondria needs more than
1000 proteins which are nuclear encoded and translocated to the mito-
chondria. The import/association of non-coding RNA including miRNA
tomitochondria is emerging [18,41–43]. ThemiRNA targets both nucle-
ar encoded andmitochondria encodedmRNA transcripts. Hence,we hy-
pothesized that increased levels of TNF-α observed in PD conditions
may alter the levels ofmiRNAwhich in turnmay regulatemitochondrial
functions and cell death. The differentially expressed miRNAs in SH-
SY5Y in the presence of TNF-α were selected from previous reports
[44]. The expression level of identiﬁed miRNAs were analyzed by real
time PCR. It was observed that hsa-miR-let-7b, hsa-miR-let-7g, hsa-
miR-103, hsa-miR-155, hsa-miR-16-5p, hsa-miR-17, hsa-miR-204,
hsa-miR-27 and hsa-miR-98 were up-regulated signiﬁcantly whereas
the levels of hsa-miR-let-7a, hsa-miR-128, hsa-miR-145, hsa-miR-
181a, hsa-miR-23a, hsa-miR-23b and hsa-miR-320a signiﬁcantly de-
creased in the presence of TNF-α (Fig. S5).
The putative targets of validated miRNAs and their biological signif-
icance were determined by combinatorial approach using miRNA func-
tion tools of starBase v.2.0 [25,45,46]. The putative targets of up-
regulated miRNAs were involved in neuronal differentiation, axonal
guidance and nerve projection development (Table A1). The targets of
up-regulated miRNAs were also clustered in basic cellular functional
like cell cycle, mRNA transport, proteasomal ubiquitin dependent
protein catabolism, mRNA transport and stabilization, protein phos-
phorylation, response to mechanical stress, acetyl CoA synthesis,
ubiquitination, ubiquitin proteasome system andmitochondrial import.
These processes are important for the mitochondrial homeostasis and
functions (Table A2). Similarly, the putative targets of downregulated
miRNA regulatemitotic cell cycle, positively regulate protein phosphor-
ylation, negatively regulate ubiquitination, inﬂammatory genes,
neuronal projections, mRNA transport, cAMP response, translation, tran-
scription, protein stabilization and negatively regulate cellular migration
(Table A3). The several cellular processes as described above targeted by
miRNAs have important implication in the progression of PD.
The starBase analysis also revealed that some of the validated
miRNAs may target nuclear encoded subunits of mitochondrial
complex-I to complex-V (Table A4). The putative targets of hsa-miR-
103, hsa-miR-128, hsa-miR-155, hsa-miR-17, hsa-miR-221, hsa-miR-
23a/b, and hsa-miR-27a/bwere found to be nuclear encodedmitochon-
drial complex I subunits: NDUFV1, NDUFS4, NDUFV1, NDUFAB1 and
NDUFB5, NDUFA1, NDUFA7 and NDUFC1, NDUSF4 respectively. As ob-
served in the above section, the mitochondrial complex-I was compro-
mised in the presence of TNF-α, hence miRNAs targeting nuclear
encoded mitochondrial complex-1 subunit were speciﬁcally analyzed
by real time PCR. The levels of miR-27a, hsa-miR-17, hsa-miR-103
and hsa-miR-155 signiﬁcantly increased in the presence of TNF-α
(Fig. 6A). The level of NDUFS4 (target of hsa-miR-27a) was decreased
signiﬁcantly in the presence of TNF-α (Fig. 6B). This suggests that
TNF-α regulates miRNAs that target mitochondrial complex-I subunits
which are critical for neuronal function. Similarly, ATP5G3, a subunit
of mitochondrial complex-V is a putative target of miR-155 and miR-
27a. It was observed that the levels of both miRNAs (miR-155 and
miR-27a) were high and the levels of ATP5G3 (target of miR-155 and
Fig. 5. TNF-α regulatesmitophagy in SH-SY5Y cells. (A) SH-SY5Y-MTRFP stable cells were transfectedwith GFP-LC3. Cells were treatedwith TNF-α for 72 h and co-localization of GFP-LC3
with redmitochondriawas analyzed by confocalmicroscopy. Scale bars, 10 μm.Graphical representations of the numbers LC3 puncta co-localizationwithmitochondria per cell in untreat-
ed and TNF-α treated condition of representative (Fig. S4B). (B) SH-SY5Y cells were treatedwith TNF-α for 72 h andmitochondrial fractionwas prepared using differential centrifugation
method and association of LC3 with mitochondria was analyzed by western blotting using LC3 speciﬁc antibody.
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(Fig. 6A and B).
The evidence in the current study suggest that hsa-miR-155 target
mitochondrial functions and previous reports [47] suggest its implica-
tion in cell death hence further experiments were done to conﬁrm its
role in TNF-α induced cell death. SH-SY5Y cells were transfected with
anti-miR-155 and cell survival was monitored in presence of TNF-α.
The cell death signiﬁcantly decreased in the presence of TNF-α in anti-
miR-155 transfected cells as compared to control (Fig. 6C). These evi-
dences suggest that TNF-α alters the expression of miRNAs that target
transcripts encoding mitochondrial complex-I and complex-V subunits
leading to mitochondrial defects and decline in ATP production during
neuronal cell death in PD.
4. Discussion
The epidemiological, GWAS and clinical reports strongly suggest
that inﬂammation is one of the major causes of DAergic neuronal loss
and cause of PD. The increased levels of TNF-α, one of the key pro-
inﬂammatory cytokines have been observed in CSF [13,48] and striatum
of the PD brain [49]. The role of TNF-α in pathogenesis of PD is not well
understood. In the current study we conclude that TNF-α regulates
miRNAs that regulate mitochondrial functions, induces oxidative stress
and apoptosis.
TNF-α is pleiotropic cytokine and can act as pro-survival or cell
death stimuli depending upon the cell type [50–53]. We used DAergic
neuronal cell line (SH-SY5Y) to elucidate the molecular mechanisms
of TNF-αmediated DAergic loss during PD stress conditions. SH-SY5Y
cells were treated with enhanced levels of TNF-α for longer duration
mimicking conditions in vivo. The presence of TNF-α speciﬁcally up-
regulates TNFR1 leading to activation of intracellular cell death path-
ways. The increased level of TNF-α leads to apoptosis in DAergic neuro-
nal cell line was clearly evident by PARP cleavage, caspase-3 andcaspase-9 activation. The increased level of TNF-α showed signiﬁcantly
increased cell death with time. This observation is in consonance with
earlier observation of the post-mortem brain of PD patients [54].
This strongly suggests that TNF-α may bind to the cognate receptor
and induce the activation of downstream caspase cascade rather than
activation of pro-survival pathway of NF-κB activation. TNF-α also sen-
sitized SH-SY5Y to cell death in the presence of rotenone, 6-OHDA and
α-synuclein induced PD stress conditions. The activation of caspase-9
in the presence of TNF-α strongly suggests the activation of mitochon-
drial mediated pathway of apoptosis.
Mitochondrial dysfunction is one of the cardinal features of the PD
[55]. TNF-α is known to regulate mitochondrial functions by enhancing
ROS, superoxide andH2O2 production [56]. These functions are critically
regulated by mitochondrial complex-I which is the entry point of the
electrons in ETC. Hence, we hypothesized that the prolonged exposure
of TNF-αmay decrease complex-I activity and mitochondrial ATP pro-
duction. The prolonged exposure of SH-SY5Y cells to TNF-α showed de-
crease in mitochondrial complex-I and ATP levels and induces ROS and
cell death. The cell death induced by TNF-αwas rescued by antioxidants
that further emphasized the role of ROS and complex-I. The evidence of
the regulation ofmitochondrial complex-I activity by TNF-α suggests its
important implication in PD stress conditions. The hypothesis is further
supported by observation in animal model of ventricular dysfunction
where TNF-α regulates ROS production by down regulating the expres-
sion of four subunits of the complex-I [57]. These observations should
be validated in animalmodels and post-mortembrain samples obtained
from PD patients.
The defective mitochondria are ubiquitinated through PARKIN and
degraded through selective process of autophagy called as mitophagy
[58]. Mitochondrial homeostasis is critical for neuronal functions
hence any alteration in mitochondrial biogenesis or the degradation
throughmitophagy may lead to neurodegeneration [59]. The evidences
here strongly suggest that the turnover of mitochondria is regulated by
Fig. 6. TNF-α regulates miRNAs targeting mitochondrial complexes. (A) The expression
levels of miRNAs which putatively target mitochondrial complex-I subunits were deter-
mined using 5S rRNA as endogenous control by qPCR (B) The expression levels of targets
comprising nuclear encoded mitochondria complex-I subunits were determined by real
time PCR using GAPDH as endogenous control. (C) SH-SY5Y cells were transfected with
anti-miR-155 and control. Cell survival was monitored using MTT assay in presence of
TNF-α. Asterisk (*) indicates that p value b 0.05, for SEM.
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conjugated by LC3 in the presence of TNF-α. The induction ofmitophagy
in the presence of rotenone is in consonance with earlier reports [60,
61]. The LC3 conjugation to mitochondria is less prominent in the pres-
ence of TNF-α as compared to rotenone. This suggests that defectivemitochondria may be accumulated as observed by decreased turnover
in the presence of TNF-α leading to generation of ROS and cell death.
The levels of mitophagy and its association with TNF-α should be also
studied in the clinical samples of PD patient.
The emerging reports strongly suggest thatmitochondrial trafﬁcking
is crucial for neuronal branching, synaptic plasticity and transmission
[62,63]. The mitochondria are immobilized at the neuronal branching
point, assist site speciﬁc de novo protein synthesis and initiate axonal
branching [63,64]. This strongly suggests that mitochondria are impor-
tant for the neuronal connectivity which is degenerated in different
neurodegenerative diseases including PD [65,66]. The optimal function-
ing ofmitochondria requires nuclear encoded genes that are transcribed
in the nucleus, translated in the cytoplasm and translocated to mito-
chondria [16]. The recent reports including ours [18,41–43] suggest
that miRNA associates with mitochondria and is important for the reg-
ulation of the target in the narrow physiological range. In consonance
to it, the current study demonstrated that miRNAs includingmitochon-
dria associated miRNA (miR-23a, miR-320a, miR-181, miR-let-7a, miR-
let-7 g a) are altered in the presence of TNF-α. Intriguingly, some of
these miRNAs: miR-103, miR-17, miR-181a, miR-23a, miR-23b, miR-
27b and miR-320 were previously reported to be enriched at synapses
[67–69]. The role of miRNAs in the regulation of synaptic functions
should be also studied in the presence of TNF-α.
The putative targets of validated miRNA suggested that miRNAmay
target the genes involved inmRNA stability, transport and transcription,
translation, phosphorylation and ubiquitination of proteins, cell cycle
and mitochondrial complex subunits. The dysregulation of these pro-
cesses and targets has been implicated in progression of PD [70–77].
In consonance with the starBase analysis of miRNA and targets, the ex-
perimental results showed that TNF-α regulates miRNAs (has-miR-27a
and hsa-miR-103) that target the nuclear encoded transcripts of mito-
chondrial complex-I subunit decreased in the presence of TNF-α. This
is further supported by observation where expression of miR-27a im-
paired mitochondrial biogenesis, structure integrity and complex-I ac-
tivity which further produced excessive ROS in human cell [78].
Similarly, TNF-α regulates the expression of miR-155 and miR-27a
which regulate the transcript levels of ATP5G3, subunit of F1-ATPase.
This helps in transport of protons across the mitochondrial inner mem-
brane to the F1-ATPase for synthesis of ATP. This hypothesis is in conso-
nance with recent report demonstrating the import of hsa-miR-181c in
mitochondria, which targets complex-IV subunits in myocardial infract
[79]. These results strongly suggest that TNF-α may regulate several
miRNAs speciﬁcally targeting nuclear encoded transcripts encodingmi-
tochondrial targeted proteins.
The data provided here strongly suggest that mitochondrial func-
tions were compromised in the presence of TNF-α leading to bioener-
getics crisis and increased cell death in dopaminergic neurons. The
study also suggests that TNF-α regulated miRNAs play important role
in the regulation of mitochondrial functions suggesting their important
implication in PD conditions. The innovation in sequencing technologies
for the last few years had shown exponential increase in the number of
miRNAs hence it is important to systematically investigate the TNF-α
regulated miRNA in dopaminergic neurons. The same needs to be vali-
dated in the tissue obtained from the patients having increased levels
of TNF-α in serum and CSF and showing the symptomsof Parkinsonism.
The studies in this direction will help to better understand the crosstalk
of inﬂammation, miRNA and mitochondria and its implication in PD.
5. Conclusions
Parkinson's disease is a devastating age related neurodegenerative
disorder. Pro-inﬂammatory cytokine like TNF-α is increased in serum,
CSF and striatum of PD patients. The current study provided evidence
that increased levels of TNF-α decrease mitochondrial complex-I, lead-
ing to oxidative stress, activation of caspase cascade leading to mito-
chondrial dysfunction and cell death. TNF-α regulated miRNAs target
460 P. Prajapati et al. / Biochimica et Biophysica Acta 1852 (2015) 451–461nuclear encoded subunits of mitochondrial ETC. The altered levels of
miRNA in the presence of TNF-α reduced the subunit of mitochondrial
complex-I and complex-V leading to decreased levels of ATP. This
study strongly suggests that TNF-α regulates miRNA targeting mito-
chondrial functions thatmay have important implication in dopaminer-
gic neuronal loss in PD.Acknowledgements
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